FDA Inspection 1046857 — Viatris Pharmaceuticals LLC

Viatris Pharmaceuticals LLC — FEI 2627208

The FDA completed an inspection of Viatris Pharmaceuticals LLC on March 28, 2018 in Barceloneta, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 28, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Barceloneta, PR (United States)

Citations

IDCFRDescription
179021 CFR 211.80(b)Handling and Storage to Prevent Contamination
180921 CFR 211.160(a)Following/documenting laboratory controls
202721 CFR 211.192Investigations of discrepancies, failures
240121 CFR 211.194(a)(4)Complete Test Data
360321 CFR 211.160(b)Scientifically sound laboratory controls